Raifeld Pavel 4

4 · Innoviva, Inc. · Filed May 6, 2026

AI-generated summary of this filing

Updated May 6, 2026

Innoviva (INVA) CEO Pavel Raifeld Receives Equity Award

What Happened

Pavel Raifeld, CEO of Innoviva, was granted equity awards on May 4, 2026: 126,646 restricted stock units (RSUs) and 312,500 derivative awards (non‑statutory stock options), each reported at an acquisition price of $0.00 (standard for awards). These are awards/conditional grants rather than open‑market purchases or sales.

Key Details

Transaction date: May 4, 2026; Form 4 filed May 6, 2026.
Award amounts and prices: 126,646 RSUs @ $0.00 (acquired); 312,500 derivative awards @ $0.00 (acquired).
Shares owned after transaction: Not disclosed in this filing.
Grant condition: Awards were granted subject to stockholder approval of Innoviva’s 2026 Equity Incentive Plan (per the Form 14A disclosure).
Vesting: 25% of each grant vests on February 20, 2027; the remaining balance vests in twelve substantially equal installments every three months thereafter, subject to continuous service.
Acceleration: Options accelerate in certain "change in control" scenarios if not assumed/replaced (provided no prior termination); both Options and RSUs may accelerate on an involuntary termination within 24 months after a change in control if assumed/substituted, subject to a release of claims.
Filing timeliness: Form 4 was filed two days after the reported grants (May 6 vs. May 4), which is within the typical Form 4 reporting window.

Context

These entries are awards (code A) — a compensation grant, not an open‑market buy or sale. The derivative line reflects stock options (non‑statutory) per the footnotes; options themselves are not exercised here. Awards reported at $0.00 indicate grants rather than cash purchases. Such grants are common for executive compensation and subject to vesting and company/stockholder approvals.

Form 4

Period: 2026-05-04

DirectorChief Executive Officer

Transactions

Award
Common Stock
[F1][F2]
2026-05-04+126,646→ 285,936 total
Award
Non-statutory Stock Option
[F1][F2]
2026-05-04+312,500→ 312,500 total
Exercise: $22.99From: 2027-02-20Exp: 2036-05-03→ Common Stock (312,500 underlying)

Footnotes (2)

[F1]The Reporting Person was conditionally granted time-vested restricted stock units ("RSUs") and non-statutory stock options ("Options"). The RSUs and Options were granted subject to stockholder approval of the Issuer's 2026 Equity Incentive Plan at the Issuer's 2026 annual meeting of stockholders on May 4, 2026, as disclosed in the Issuer's Schedule 14A filed with the Securities and Exchange Commission ("SEC") on March 24, 2026.
[F2]Twenty-five percent of each of the RSUs and Options vest on February 20, 2027 and the balance will vest in twelve (12) substantially equal installments thereafter on each three (3) month anniversary of the initial vesting date, in each case, provided the Reporting Person has provided continuous service to the Issuer through the applicable vesting date, with accelerated vesting (i) with respect to the Options, in the event of a "change in control" (as defined in the Issuer's 2026 Equity Incentive Plan) in which the options are not assumed or replaced, provided that the Reporting Person has not experienced a termination prior to such "change in control," or (ii) with respect to the Options and the RSUs, in the event that the Reporting Person experiences an "involuntary termination" of employment within 24 months following a "change in control" where such awards are assumed or substituted, subject to an effective release of claims.

Signature

/s/ Pavel Raifeld|2026-05-06

1 file